configunitprice | 198 |
---|
SKU |
CMS3173 |
USA Brand Name |
Mitotax |
Strength |
300mg/50ml |
Generic Name |
Paclitaxel |
Manufacturer |
Dr Reddy's Laboratories |
Paclitaxel is the generic version for Mitotax 300 mg/ 50 ml Injection
Mitotax 300 mg/ 50 ml Injection contains an active ingredient, Paclitaxel, which is used in the treatment of breast cancer, non-small cell lung cancer and pancreatic cancer. Breast cancer is type of cancer that develops from breast tissue. Symptoms of breast cancer include lump in the breast, dimpling of the skin, a change in breast shape, and fluid coming from the nipple, an inverted nipple, or a red/ scaly patch of skin. Non-small-cell lung cancer (NSCLC) is epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLCs are comparatively insensitive to chemotherapy, compared to small cell carcinoma. Pancreatic cancer starts when abnormal cells in the pancreas grow & divide out of control and form a tumor. The pancreas is a gland located deep in the abdomen, between the stomach & the spine which makes enzymes that help digestion and hormones that control blood-sugar levels. This medicine is available at all the leading pharmacy, drugstores, and medical supply stores & must be taken by doctor’s prescription only.
Dr Reddy's Laboratories Ltd. is one of the leading pharmaceutical companies which manufacture Mitotax 300 mg/ 50 ml Injection. It can be purchased from our online pharmacy.
Mitotax 300 mg/ 50 ml Injection contains an active ingredient, Paclitaxel, which is available in the various strengths & substitutes at all the leading pharmacy, drugstores, and medical supply stores.
Mitotax 300 mg/ 50 ml Injection is used in the treatment in following conditions:
Mitotax 300 mg/ 50 ml Injection has an active ingredient; Paclitaxel is an anti-cancer medicine which works by interfering with the microtubule structures which help the cancer cells to divide and multiply. Paclitaxel is a taxoid antineoplastic agent used as first-line and succeeding therapy for the treatment of advanced carcinoma of the ovary, & other various cancers including breast cancer. Paclitaxel is a new antimicrotubule agent which promotes the assembly of microtubules from tubulin dimers & stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic restructuring of the microtubule network which is essential for vital interphase & mitotic cellular functions. Paclitaxel also induces abnormal arrays or "bundles" of microtubules throughout the cell cycle & multiple asters of microtubules during mitosis. This slows the growth of cancer cells & eventually kills them.
Make sure that:
You should not take Mitotax 300 mg/ 50 ml Injection if you:
Mitotax 300 mg/ 50 ml Injection contains an active ingredient, Paclitaxel, which is used in the treatment of breast cancer, non-small cell lung cancer and pancreatic cancer. This medicine is available in various strengths and substitutes & must be given on doctor’s prescription only. You should consult your doctor for dosage and time because age and severity of the disease differ from person to person and it can only be judged by your doctor.
Adults are advised to take Mitotax 300 mg/ 50 ml Injection at a fixed time with or without food as instructed by your Doctor. You must take this medicine regularly on time for better results.
As Mitotax 300 mg/ 50 ml Injection is available in various strengths and substitutes, Patients are always advised to follow their doctor’s prescriptions and instructions to take Mitotax 300 mg/ 50 ml Injection. Do not take the Injection on your own and for longer time than suggested by doctor.
Mitotax 300 mg/ 50 ml Injection should be taken at a fixed time as directed by your doctor. Your doctor or nurse will give you Mitotax 300 mg/ 50 ml Injection. Kindly do not self administer this medicine.
You are always advised to take Mitotax 300 mg/ 50 ml Injection as prescribed. Do not start/stop using this medicine yourself. Follow all the instructions given by your doctor. Do not take the Injection in smaller or larger amount or for longer than suggested by your doctor.
You must seek emergency medical attention and/ or contact your physician immediately in case of any overdose symptoms. Since Mitotax 300 mg/ 50 ml Injection is used in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated immediately by your doctor if they observe overdose symptoms.
The missed dosage of the medicine must be taken by the patient as soon as possible. It is strictly recommended to skip the missed dosage of the medicine if it is already time for your next scheduled dosage. You must not take double dosage of the medication to make up for the missed dosage. Since Mitotax 300 mg/ 50 ml Injection is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dosage is very low.
Few medicines have been reported to interact with Mitotax 300 mg/ 50 ml Injection. This can produce some unwanted effects and/or cause your drug not to work properly. You must always tell your doctor if you are taking other medication/ Supplements so that well planned medication can be given. It interacts with the following medicines:
It can also interact with following disease condition:
Mitotax 300 mg/ 50 ml Injection can worsen the conditions like:
Mitotax 300 mg/ 50 ml Injection should be taken as prescribed by your doctor. Do not take this medicine for shorter or longer period than suggested by the Doctor.
Store the Mitotax 300 mg/ 50 ml Injection at room temperature in dark and dry place. Make sure the Injection is intact and not damaged while storing.